Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Multi-morbid > Chemotherapy-Induced Diarrhoea, Constipation, Mucositis > Flashcards

Chemotherapy-Induced Diarrhoea, Constipation, Mucositis Flashcards

(63 cards)

Start Studying
1
Q

Other predictive factors of CID

A
  1. First cycle of chemotherapy
  2. Cycle duration greater than 3 weeks
  3. Concomitant neutropenia
  4. Other symptoms such as mucositis, vomiting, anorexia, or anaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Risk factors for CID

A
  1. Age greater than 65 years
  2. Female
  3. ECOG performance status of at least 2
  4. Bowel inflammation or malabsorption
  5. Bowel malignancy
  6. Biliary obstruction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Potential Causative Agents for Chemotherapy-Induced Diarrhoea

A

a. Cisplatin/Oxaliplatin
b. Cyclophosphamide
c. Cytarabine
d. 5-FU/Capecitabine
e. Gemcitabine
f. Methotrexate
g. Doxorubicin/Daunorubicin
h. Taxanes
i. Irinotecan/Topotecan
j. Oral Targeted Therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MOA of CID

A

Direct damage and inflammation to mucosa of intestine, which leads to imbalance between absorption and secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Severity grading for CID

A

CTCAE Version 5.0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Grade 1

A

Increase of <4 stools per day above baseline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Grade 2

A

Increase of 4-5 stools per day above baseline
Limiting ADL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Grade 3

A

Increase of ≥7 stools per day above baseline
Hospitalisation needed
Limiting self-care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Grade 4

A

Life threatening
Urgent intervention needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Grade 5

A

Death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Criteria for complicated CID

A

● Grade 3 or 4
● Grading 1 or 2 with at least one of the following
○ Cramping
○ >Grade 2 N/V
○ Decreased performance status
○ Fever
○ Sepsis
○ Neutropenia
○ Frank bleeding
○ Dehydration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Criteria for uncomplicated CID

A

Grade 1 or 2
No complicating signs or symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CID goals of therapy

A
  1. Decrease morbidity and mortality from CID
  2. Improve QOL and ADL
  3. Improve recovery of intestinal mucosa
  4. Decrease hospitalisation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Management of uncomplicated CID

A
  1. Withhold chemotherapy for Grade 2
  2. Diet modifications
  3. If diarrhoea persists after 12-24 hours…
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When to resume chemotherapy for Grade 2?

A

When symptoms resolve; consider dose reduction of drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Diet modifications for uncomplicated CID

A

a. Oral hydration with 8-10 large glasses of clear liquids
b. Loperamide
c. If diarrhoea improve after 12-24 hours, continue with diet modifications and begin to add solid food

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

If diarrhoea persists after 12–24 hours

A

1) Schedule loperamide 2 mg every 2 hours
2) Start oral antibiotics.
3) For diarrhoea that progresses to severe or complicated, treat as such.
4) For diarrhoea that persists as uncomplicated 12– 24 hours after scheduled loperamide, begin octreotide or other second-line agent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Administration of Loperamide

A

Loperamide 4 mg by mouth, then 2 mg by mouth every 4 hours or after every episode of diarrhoea. Continue until 12 hours free of diarrhoea, then stop.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Management of complicated CID

A

1) Withhold chemotherapy
2) Restart at decreased dosage
3) Administer octreotide
4) Start IV fluid hydration
5) Start IV antibiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Administration of octreotide

A

SC 100–150 mcg TDS or
IV with dose escalation up to 500 mcg TDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

MOA of loperamide

A

Opioid that inhibits smooth muscle contraction of intestine to decrease motility (primary neurotransmitter is acetylcholine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Adverse effects of Loperamide

A

a. Constipation
b. Abdominal pain
c. Dizziness
d. Rash
e. Bloating
f. N/V
g. Dry mouth
h. Drowsiness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Which grade does Loperamide has limited efficacy?

A

Grade 3-4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

High dose of Loperamide has been associated with ______.

A

Paralytic ileus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Maximum daily dose of Loperamide
16mg
26
MOA of Octreotide
Causes decreased hormone secretion, which - increases transit time within intestine - decreases secretion of fluid - increases absorption of fluid and electrolytes
27
Adverse effects of Octreotide
1. Bradycardia 2. Arrhythmias 3. Constipation 4. Abdominal pain 5. Enlarged thyroid 6. N/V 7. Headache and dizziness
28
When is Octreotide beneficial?
5-FU and irinotecan-induced CID
29
Recommended dose of Octreotide
100-150 mcg SC TDS May increase at 50 mag increments after 24 hours to 500 mcg TDS of continuous IV
30
Non-pharmacological management of CID
1. Probiotics with lactobacillus to prevent 2. Diet modification
31
Diet modification
1. Avoid caffeine, alcohol, fruit juice, foods that contain lactose, foods that are spicy or high in fat or fibre, or dietary supplements with high osmolarity 2. Up to 10% of patients experience 5-FU–induced lactose intolerance because lactase activity can be lost temporarily 3. Lactose-containing foods should be avoided for at least a week after CID has resolved 4. Eat small, frequent meals 5. BRAT diet (bananas, rice, applesauce, toast) 6. More than 3 L of clear fluids containing salt and sugar 7. Electrolyte-containing fluids are ideal
32
Irinotecan-associated diarrhoea MOA
Irinotecan is a selective, reversible inhibitor of acetylcholinesterase leading to a cholinergic response MOA: inhibits acetylcholine at muscarinic receptor as a competitive antagonist
33
Management of Irinotecan-associated Diarrhoea
Early (within 24 hours): Atropine 0.25-1 mg (maximum 1.2 mg) SC or IV Late (after 24 hours): Loperamide
34
Adverse effects of Atropine
1. Insomnia, dizziness 2. Tachycardia, blurred vision, dry mouth 3. Constipation
35
Contraindication of atropine
Glaucoma
36
Symptoms of Constipation
- Bloating/ feeling of fullness - Cramping or pain - Gas/ flatulence - Belching - Loss of appetite - No regular bowel movement for ≥2 days - Straining to have a bowel movement - Small hard stools that are difficult to pass - Rectal pressure - Leakage of small amounts of stool resembling diarrhoea - Swollen, or distended, abdomen - N/V
37
Factors that Increase Risk of Developing Constipation (1)
Lowered fluid intake and dehydration
38
Factors that Increase Risk of Developing Constipation (2)
Loss of appetite (anorexia)
39
Factors that Increase Risk of Developing Constipation (3)
Lack of fibre or bulk-forming foods in the diet
40
Factors that Increase Risk of Developing Constipation (4)
Vitamin or mineral supplements such as iron or calcium pills
41
Factors that Increase Risk of Developing Constipation (5)
Overuse of laxatives
42
Factors that Increase Risk of Developing Constipation (6)
Low level of physical activity/alot of bed rest
43
Factors that Increase Risk of Developing Constipation (7)
Thyroid problems
44
Factors that Increase Risk of Developing Constipation (8)
Depression
45
Factors that Increase Risk of Developing Constipation (9)
High levels of calcium or potassium in the blood
46
Factors that Increase Risk of Developing Constipation (10)
Cancer growing into the large intestine (bowel)/pressing on spinal cord
47
Factors that Increase Risk of Developing Constipation (11)
- Pain relievers, especially opioid narcotic medicines (morphine/ codeine) - Chemotherapy drugs (eg. vinca alkaloids – vincristine vinblastine/ vinorelbine) - Antinausea drugs (ondansetron, granisetron/ anticonvulsant drugs)
48
Preventing Constipation
- Eat more fibre - Eat natural laxatives (vegetables, caffeine, prunes) - Increase physical activity - Ensure sufficient caloric intake
49
Managing Constipation
1. Stool softeners 2. Laxatives - Promote or stimulate bowel activity - Increase fibre or product bulk - Suppository foam that help promote bowel activity 3. Enemas
50
When should suppository/enema not be recommended?
When WBC or platelet counts are low → risk of infection or bleeding
51
Pathophysiology of Mucositis
Damage to mucosa of the oral cavity, pharynx, larynx, oesophagus and GI tract due to cancer therapy
52
How does chemotherapy/radiation cause mucotitis?
Direct damage to epithelial stem cells - Tissue response varies by seasonal and circadian changes - Targeted therapies (eg. cetuximab, bevacizumab, rituximab) and a variety of small-molecule inhibitors have demonstrated the potential to cause a variety of GI toxicities, including mucositis
53
Epidermal growth factor
Maintain mucosal integrity - EGFR can be found in the oesophagus and levels are increased in inflamed mucosa
54
Five stages of mucositis
1. Initiation 2. Upregulation 3. Signalling and amplication 4. Ulceration 5. Healing
55
Initiation
- Direct toxicity to cells, tissues and vasculature - Generation of oxidative stress and ROS - Increased vascular permeability → accumulation of toxic drugs
56
Upregulation
- ROS damage DNA → epithelial cell death - Production of pro-inflammatory cytokines
57
Signalling and amplification
- Pro-inflammatory cytokines (TNF⍺, IL1β, IL6) are released - Positive feedback
58
Ulceration
- Atrophy and mucosal breakdown - Oxidative stress leads to inflammatory infiltrates - Macrophages activated by colonising bacteria
59
Healing
- Proliferation of epithelial cells - Return of local flora
60
Grading of Mucositis
0: no evidence of mucositis 1: erythema and soreness 2: ulcers; eating solids 3: ulcers; requires liquid diet 4: ulcers; not able to take PO
61
API of oracare suspension
Nystatin 125.000U Tetracycline 62.5mg Hydrocortisone 5mg Diphenhydramine 11.5mg/10mL
62
Administration of oracare suspension
Administer after food, must swallow Counsel patient that swallowing can help to coat the throat and enter the gut, allowing for full protection (especially for throat ulcers)
63
What is the antibiotic regimen for complicated CID?
Ciprofloxacin for 7 days

Multi-morbid (5 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions